Titlebook: New Family Interventions and Associated Research in Psychiatric Disorders; Gedenkschrift in Hon Annette Schaub Book 2002 Springer-Verlag/Wi

adroit

令人悲傷

gratify

商談

Early Psychosis, Schizophrenia and the Family an earlier age of onset than females (mean difference: 5 years, Angermeyer and Kühn, 1988). The early phase of psychosis and schizophrenia can thus be seen as a ‘critical period’ with major implications for the prevention of disease and psychosocial deterioration (Birchwood et al., 1998). Early rec

abnegate

Examining Patients’ Perceptions of their Relatives’ Expressed Emotiontressor for patients with psychiatric illnesses, the mechanism by which they exert their influence is still unclear. Measures of EE have traditionally been made by counting the number of criticisms and making ratings of emotional overinvolvement (EOI) based on the Camberwell Family Interview (Vaughn

concubine

Patient Psychopathology and Parental Expressed Emotion in Schizophrenia Revisitedhis research it was also suggested that there is some reciprocity in behaviors of high EE parents and their psychotic offspring: being exposed to higher levels of odd and disruptive behaviors of their offspring elicits higher levels of criticism and/or overinvolvement.

Neuropeptides

Principles and Results of Family Therapy in Schizophreniaes worldwide resulting in a relapse rate nine months after discharge of 52% for patients living with a HEE relative in contrast to 22 % for patients living in a LEE family (Butzlaff and Hooley, 1998).

nauseate

Bipolar Disorder and Family Psychoeducational Treatment: A Comparison of One-Year Effects Using Repe operational criteria for the course event descriptors ., and . based on symptomatic variation in severity and duration. Thus, treatment efficacy may be shown by establishing a longer time to relapse or shorter time to remission, by comparing duration of time spent in a symptomatic state, or simply

Cubicle

Illness Self-management Programs in Schizophrenia and Severe Affective Disordersd controlled studies in this field. Two coping-oriented programs recently developed in Munich, one for schizophrenia, the other for depression are described as well as the results of randomised controlled trials for each. The chapter concludes with a discussion of which treatment elements in illness

conspicuous